Navigation Links
Boston Scientific Receives Exclusive Expanded Indication for Its CRT-Ds
Date:9/16/2010

NATICK, Mass., Sept. 16 /PRNewswire-FirstCall/ -- Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for its cardiac resynchronization therapy defibrillators (CRT-Ds), including the COGNIS® CRT-D.  The exclusive expanded indication is effective immediately and makes Boston Scientific CRT-Ds the only devices approved by the FDA for patients in all New York Heart Association (NYHA) classes of heart failure(1).

The Company's CRT-Ds had previously been approved for NYHA Class III and IV patients.  The expanded indication approves Boston Scientific CRT-Ds for use in high risk(2) NYHA Class I and II patients with Left Bundle Branch Block(3) (LBBB).  These patients accounted for 70 percent of the MADIT-CRT clinical trial population.

"The MADIT-CRT trial demonstrated that Boston Scientific's CRT-Ds reduce death and heart failure events, even for patients without symptoms," said Kenneth Stein, M.D., Senior Vice President and Chief Medical Officer, CRM, for Boston Scientific's Cardiology, Rhythm and Vascular Group.  "Preventing or delaying a first heart failure event in NYHA Class I and II patients with LBBB is critical because these patients are eight times more likely to have a recurring event after their initial event."

In response to a request from the FDA, Boston Scientific worked with the MADIT-CRT Executive Committee to perform further analysis of the trial data to determine if there were additional criteria to identify patients at risk for heart failure.  The Company's analysis showed that LBBB was the best baseline characteristic to differentiate which Class I and II patients would be most likely to benefit from a CRT-D.  MADIT-CRT data demonstrated that patients with LBBB who received CRT-D therapy showed a relative risk reduction of al
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Regado Biosciences to Present at the Stifel Nicolaus Healthcare Conference 2010 on September 16, 2010 in Boston, Massachusetts
2. Boston Millennia Partners Portfolio Company CardioMEMS Signs Equity Investment and Exclusive Option to be Acquired for an Additional $375,000,000
3. Childrens Hospital Boston and Particle Sciences Cooperate on Translational Medicine Efforts
4. Boston Scientifics Womens Health Products Featured in Studies at the Joint Annual Meeting of the International Continence Society and International Urogynecological Association
5. Boston Scientific Launches Neuroform EZ(TM) Stent System in U.S. and Europe
6. Regado Biosciences to Present at the 2010 Wells Fargo Healthcare Conference on June 24, 2010 in Boston, Massachusetts
7. Cumberland Pharmaceuticals to Present at the Wells Fargo Healthcare Conference in Boston on June 23, 2010
8. Boston Scientific Announces Japanese Approval for PROMUS(R) Everolimus-Eluting Coronary Stent System
9. Boston Scientific Announces Settlement of DOJ Investigation Relating to Post-Market Surveys Conducted By Guidant
10. Boston Scientific Announces Election of Nelda Connors to Its Board of Directors
11. Boston Scientific Announces Pricing of $2 Billion of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... NEW YORK , Sept. 17, 2014 /PRNewswire/ ... Summary GlobalData,s new report, "Germany ... market data on the Germany Gynecological Devices market. ... dollars, volume (in units) and average prices (in ... Devices (Transcervical Sterilization Devices (Micro-inserts) and Mechanical Sterilization ...
(Date:9/17/2014)... SANTA MONICA, Calif. , Sept. 17, 2014 /PRNewswire-USNewswire/ ... who is at the White House today for National ... Proposition 46 that consumer advocates released today. Consumer advocates ... woman who spoke out after losing her ... later discovering that the doctor had a history of ...
(Date:9/17/2014)... , Sept. 17, 2014  Decision ... colitis (CD/UC) patients eligible for biologic therapy, ... a biologic. Surveyed gastroenterologists cite patients, discomfort ... for low penetration rates, followed by cost-related ... UC patients receiving biologics, Janssen Biotech,s Remicade ...
Breaking Medicine Technology:Germany Gynecological Devices Market Outlook to 2020 2Germany Gynecological Devices Market Outlook to 2020 3Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 2Doctor Recovering From 100-Pill-A-Day Addiction Stars In New Ad Supporting Prop 46; Appears At White House for National Recovery Month, Says Consumer Watchdog Campaign 3The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3
... OncoSec Medical Incorporated (OTCBB:ONCS), which is developing ... to treat solid tumor cancers, today announced that ... and Lakeland Comprehensive Cancer Center in Lakeland, FL ... are screening patients for the Phase II metastatic ...
... International, Inc. (NASDAQ: BDSI ) announced that ... of further litigation in the patent infringement lawsuit previously ... that the case would be stayed pending resolution by ... proceedings and follows the recent rejection by the USPTO ...
Cached Medicine Technology:OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 2OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 3OncoSec Initiates Two Additional Clinical Sites for Phase II Metastatic Melanoma Trial 4Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation 2Federal Court Grants Request by BioDelivery Sciences for Stay of MonoSol Litigation 3
(Date:9/18/2014)... September 18, 2014 First Choice ... emergency rooms in the United States, named Douglas J. ... Missouri City-Lakes facility. , “We are pleased to ... medical director of our new Missouri City-Lakes facility,” said ... Choice Emergency Room. , Dr. Harrison received his ...
(Date:9/18/2014)... 9Lover.com, an internationally well-known designer and leader in the ... for its maternity wedding outfits. Now, all the company’s ... wedding dresses on its website. , 9Lover.com ... The company’s development manager believes the cheap maternity wedding ... current special offer will last until September 29, 2014. ...
(Date:9/17/2014)... ball gown is the most formal female attire for ... the floor, made of luxurious fabric, delicately and exotically ... and retailer, has delightedly unveiled its new series of ... at discounted rates. , Most versions are cut off ... worn with a stole (a formal shawl in expensive ...
(Date:9/17/2014)... D.C. (PRWEB) September 18, 2014 The ... in the Match , a comprehensive analysis of the ... to a preferred specialty. The new edition is ... data by specialty for U.S. allopathic medical school senior ... delighted to be able to provide this new edition ...
(Date:9/17/2014)... Creek, MI (PRWEB) September 17, 2014 ... , an open-ended drug and alcohol treatment program that ... them a solid foundation in recovery they can believe ... depression. , “About 20% of Americans who are afflicted ... both,” commented A Forever Recovery’s CEO Per Wickstrom ...
Breaking Medicine News(10 mins):Health News:First Choice Emergency Room Announces Dr. Douglas J. Harrison as Medical Director of Missouri City - Lakes, Texas Facility 2Health News:Discounted Maternity Wedding Dresses For 2014 Introduced By 9Lover.com 2Health News:Fecbek.com: Ladies Can Be Elegant Enough to Draw Everyone’s Attention by Wearing Trendy Ball Gowns 2Health News:Just Released: Charting Outcomes in the Match for the 2014 Main Residency Match® 2Health News:Just Released: Charting Outcomes in the Match for the 2014 Main Residency Match® 3Health News:Latest A Forever Recovery Blog Post Explores the Link Between Addiction and Depression 2Health News:Latest A Forever Recovery Blog Post Explores the Link Between Addiction and Depression 3
... BRAUNFELS, Texas, Feb. 5 The following,release was issued ... 59, car crash victim and ten-year resident at the,Eden ... Store EVP of Operations, Dan Gibbens, The SCOOTER ... Store Gift of Mobility Administrator, Betty Doeppenschmidt, of ...
... Outsources Billing, Accounts Receivable Services, BIRMINGHAM, ... Practice Services unit has completed an agreement ... Paramedical Services,one of the largest medical transport ... and software for billing and accounts,receivable management., ...
... Pa., Feb. 5 West Pharmaceutical,Services, Inc. (NYSE: ... Chairman and Chief Executive Officer, and William Federici, Chief,Financial ... Healthcare,Services Conference at 3:00 p.m. on February 11, 2008 ... corporate presentation document will be posted on the,investor link ...
... ... to LYFT, PALM SPRINGS, Calif., Feb. 5 ... its 12th Annual Winter,Symposium in Palm Springs, Calif. The meeting, which will ... using,high-risk donors, will open with a discussion of the proposed organ,allocation system ...
... 5 /PRNewswire-FirstCall/ - CRH Medical Corporation,(CRM:TSX-V) announced today ... had,13,461 patient visits at its Centers for Colorectal ... period in 2006., Commenting on this achievement, ... 2007, we demonstrated the strong demand for the ...
... 10:00am EST Today, LENEXA, Kan., Feb. 5 ... of ClosedLoop(TM) clinical systems,for blood and medication management, reported ... of $8,659,000 compared to $11,262,000 in the,comparable quarter in ... or a loss of four cents per fully diluted ...
Cached Medicine News:Health News:Regional Paramedical Services and DST Health Solutions Complete Business Process Outsourcing Agreement 2Health News:West Pharmaceutical Services to Present at the 2008 UBS Global Healthcare Services Conference 2Health News:AST to Address New Concept in Organ Allocation at March 13-16 Winter Symposium 2Health News:CRH Medical Corporation announces substantial increase in patient visits 2Health News:Mediware Reports Second Quarter Fiscal 2008 Results 2Health News:Mediware Reports Second Quarter Fiscal 2008 Results 3Health News:Mediware Reports Second Quarter Fiscal 2008 Results 4